Marc Schmitz

7PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 06, 2025
Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma.

Franziska Baenke, Antonia Stammberger, Ulrich Sommer

|Dec 09, 2024
Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS.

Karin D Prummel, Kevin Woods, Maksim Kholmatov

|Oct 02, 2024
TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells.

Neibla Priego, Ana de Pablos-Aragoneses, María Perea-García

|Apr 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.

Florian Hornsteiner, Janine Vierthaler, Helen Strandt

|Oct 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Annika Nelde, Heiko Schuster, Jonas S Heitmann

|Nov 08, 2022
Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner.

Tina Schumann, Santiago Costas Ramon, Nadja Schubert

Pageof 2

Frequent Collaborators

3 joint publications

Luise Rupp

2 joint publications

Adrian M Seifert

2 joint publications

Antonia Stammberger

1 joint publications

Tina Schumann